Dr. Amit Mahipal is currently a professor of Hematology and Oncology at the University Hospitals Seidman Cancer Center in Ohio. His primary area of research focus has been pancreatic and hepatobiliary cancers. Dr. Mahipal has developed early- to late-phase clinical trials and evaluated biomarkers that could predict response to therapy in gastrointestinal malignancies, especially pancreatic and hepatobiliary cancers. He completed medical school at Maulana Azad Medical College in India, did his residency in Internal Medicine at the University Of Connecticut Health Center, and completed his fellowship in Hematology/Oncology at Thomas Jefferson University Hospital.